Abcam plc (NASDAQ: ABCM) has agreed to acquire BioVision Inc, a wholly-owned Boai NKY Medical Holdings Ltd subsidiary, for $340 million in cash. The Milpitas, California-based BioVision is a ...
CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", “the Company” or "the Group"), a global leader in the supply of life science research ...
(RTTNews) - Abcam Plc (ABCM, ABC.L), a supplier of life science research tools, announced Monday that it has entered into a definitive agreement to acquire BioVision, Inc., a unit of Boai NKY Medical ...
Dr David Amudavi, Executive Director, Biovision Africa Trust (right) and Andreas Schriber, Board Chair, Biovision Africa Trust during the launch of the organization's strategic plan in Nairobi.
CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", “the Company” or "the Group"), a global leader in the supply of life science research ...
BioVision started supplying Abcam in 2003, and the transaction represents a compelling strategic fit for Abcam. Abcam plans to fund the acquisition from existing cash resources and a partial drawdown ...
2 August 2021, Cambridge, UK – Abcam plc ("Abcam", “the Company” or "the Group") (AIM LSE: ABC; Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces that it has ...
Founded in 1999 and located in Milpitas, California, BioVision is a global supplier of life science research tools to support research, diagnostics, and drug discovery. The company is a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback